How do I Perform a Laparoscopic Removal of a Pelvic Retroperitoneal Schwannoma

Endometriosis Pelvic Clinical Trial

— PRS  

Official title:

How do I Perform a Laparoscopic Removal of a Pelvic Retroperitoneal Schwannoma

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06313411
• Other study ID #: 8778
• Status: Recruiting
• Start date: November 23, 2022
• Est. completion date: April 2024

Study information

• Verified date: December 2023
• Source: University Hospital, Strasbourg, France
• Contact: Emilie FALLER, MD
• Phone: 33 3 88 12 63 87
• Email: emilie.faller[@]chru-strasbourg.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Schwannomas are mainly benign tumors, which develop mainly in the skull or in the cervical region. Retroperitoneal location is rare, since it represents between 0.5 and 5% of scwhanomas. The malignant retroperitoneal form is, however, more common than in other locations.

Retroperitoneal schwannoma is often discovered during the exploration of unexplained lumbo-pelvic pain, or in the face of compression of nearby organs. Abdominopelvic CT and magnetic resonance imaging are essential to characterize the mass and verify its extension. The precise diagnosis is based on the pathological examination of the part, and complete surgical excision is the standard treatment.

Acquiring the surgical techniques and skills necessary to carry out these types of procedures is essential to providing optimal patient care.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1
• Est. completion date: April 2024
• Est. primary completion date: April 2024
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult patient (=18 years old)

• suffering from symptomatic deep pelvic endometriosis

• having received treatment at the Strasbourg University Hospital during 2021 for a retro-peritoneal pelvic carcinoma

• having not expressed, after information, the reuse of their data for the purposes of this research.

Exclusion Criteria:

• Patient who expressed her opposition to participating in the study

Related Conditions & MeSH terms

• Endometriosis
• Endometriosis Pelvic
• Neurilemmoma

Locations

Country	Name	City	State
France	Service de Gynécologie Obstétrique - CHU de Strasbourg - France	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	laparoscopic removal of a retroperitoneal pelvic schwannoma	The aim of this research is to train surgeons to perform laparoscopic removal of a retroperitoneal pelvic schwanoma	Through study completion, an average of 1 month